학술논문

Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma
Document Type
Article
Source
In: Leukemia. (Leukemia, 1 October 2014, 28(10):2049-2059)
Subject
Language
English
ISSN
14765551
08876924